Cargando…

Proposed PBPK Model to Predict Infant Exposure to Toxic Chemicals in Breast Milk

Detalles Bibliográficos
Autor principal:	Soldin, OP
Formato:	Texto
Lenguaje:	English
Publicado:	2002
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241094/ https://www.ncbi.nlm.nih.gov/pubmed/12440394

Ejemplares similares

Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure.
por: Clewell, Rebecca A, et al.
Publicado: (2002)

PBPK model reporting template for chemical risk assessment applications
por: Tan, Yu-Mei, et al.
Publicado: (2020)

Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-Feeding
por: Garessus, Estella Dora Germaine, et al.
Publicado: (2019)

Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
por: Kuepfer, L, et al.
Publicado: (2016)

Nurturing and breast-feeding: exposure to chemicals in breast milk.
por: Somogyi, A, et al.
Publicado: (1993)

Infant exposure to chemicals in breast milk in the United States: what we need to learn from a breast milk monitoring program.
por: LaKind, J S, et al.
Publicado: (2001)

Infant exposure to lithium through breast milk
por: Imaz, M.L., et al.
Publicado: (2021)

Systematic Review Protocol for the Current State of Chemical Exposure in Infants via Breast Milk, Artificial Milk and Dairy Products
por: Mahmoud, Manal A. M., et al.
Publicado: (2021)

Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and Simulation
por: Le Merdy, Maxime, et al.
Publicado: (2022)

Current PBPK Models: Are They Predicting Tissue Drug Concentration Correctly?
por: Ibarra, Manuel, et al.
Publicado: (2020)

Infant exposure to dioxin-like compounds in breast milk.
por: Lorber, Matthew, et al.
Publicado: (2002)

Advanced In Vivo Prediction by Introducing Biphasic Dissolution Data into PBPK Models
por: Denninger, Alexander, et al.
Publicado: (2023)

Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK Modeling
por: Rowland Yeo, Karen, et al.
Publicado: (2020)

Exposure Assessment of Infants to Aflatoxin M(1) through Consumption of Breast Milk and Infant Powdered Milk in Brazil
por: Ishikawa, Angélica T., et al.
Publicado: (2016)

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK
por: Wagner, C, et al.
Publicado: (2015)

PBPK modeling and simulation in drug research and development
por: Zhuang, Xiaomei, et al.
Publicado: (2016)

Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat
por: Sánchez-Dengra, Bárbara, et al.
Publicado: (2021)

Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling.
por: Yang, R S, et al.
Publicado: (1998)

Mechanistic prediction of food effects for Compound A tablet using PBPK model
por: Li, Xueqing, et al.
Publicado: (2017)

Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling—A Contribution from the ConcePTION Project
por: Nauwelaerts, Nina, et al.
Publicado: (2023)

Permeability of Gemcitabine and PBPK Modeling to Assess Oral Administration
por: Ferreira, Abigail, et al.
Publicado: (2021)

PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and Fetus
por: Szeto, Ke Xu, et al.
Publicado: (2021)

A Workflow for Global Sensitivity Analysis of PBPK Models
por: McNally, Kevin, et al.
Publicado: (2011)

PBPK Modeling on Organs-on-Chips: An Overview of Recent Advancements
por: Yang, Yi, et al.
Publicado: (2022)

Comprehensive PBPK model to predict drug interaction potential of Zanubrutinib as a victim or perpetrator
por: Wang, Kun, et al.
Publicado: (2021)

A permeability‐ and perfusion‐based PBPK model for improved prediction of concentration‐time profiles
por: Korzekwa, Ken, et al.
Publicado: (2022)

Complex Mixtures: Array PBPK Modeling of Jet Fuel Components
por: Sterner, Teresa R., et al.
Publicado: (2023)

Environmental Chemicals in Breast Milk and Formula: Exposure and Risk Assessment Implications
por: Lehmann, Geniece M., et al.
Publicado: (2018)

PBPK Modeling of Azithromycin Systemic Exposure in a Roux-en-Y Gastric Bypass Surgery Patient Population
por: Avvari, Suvarchala Kiranmai, et al.
Publicado: (2023)

Cross-sectional assessment of infants’ exposure to toxic metals through breast milk in a prospective cohort study of mining communities in Ghana
por: Bansa, David Kwaku, et al.
Publicado: (2017)

Exposure of infants to organochlorine pesticides from breast milk consumption in southwestern Ethiopia
por: Mekonen, Seblework, et al.
Publicado: (2021)

The Milk of Eclamptic Mothers: Its Toxicity to Infants Considered
Publicado: (1912)

Acrylamide Content in Breast Milk: The Evaluation of the Impact of Breastfeeding Women’s Diet and the Estimation of the Exposure of Breastfed Infants to Acrylamide in Breast Milk
por: Mojska, Hanna, et al.
Publicado: (2021)

Prediction of Pharmacokinetics and Penetration of Moxifloxacin in Human with Intra-Abdominal Infection Based on Extrapolated PBPK Model
por: Zhu, LiQin, et al.
Publicado: (2015)

Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective
por: Riedmaier, Arian Emami, et al.
Publicado: (2020)

Infants’ Exposure to Aflatoxin M1 from Mother’s Breast Milk in Iran
por: Ghiasian, SA, et al.
Publicado: (2012)

A proposed approach to study the toxicology of complex mixtures of petroleum products: the integrated use of QSAR, lumping analysis and PBPK/PD modeling.
por: Verhaar, H J, et al.
Publicado: (1997)

Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2021)

PBPK Model for Atrazine and Its Chlorotriazine Metabolites in Rat and Human
por: Campbell, Jerry L., et al.
Publicado: (2016)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_erutuogg9glg82ldrft0mmr5hi